Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial

• Status: Completed
• Trial end date: 2012-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this multicenter trial is to determine if indomethacin prevents bleeding in the brain of very low birth weight preterm infants.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yale University
• Treatments: Indomethacin

Criteria

• Preterm infants < 1250 g birth weight

• Admitted to participating institution < 6 hrs of age

• No evidence for congenital malformations

• Cranial US at 6 postnatal hours without evidence of Grades III - IV intraventricular hemorrhage